Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Rescuers searching the hazardous slopes of Indonesia’s Mount Marapi volcano found more bodies among the climbers caught by a surprise eruption two days ago, raising the number of confirmed and presumed dead to 23.
The maker of Ozempic is suing two pharmacies in Florida for allegedly selling impure versions of the popular weight loss and diabetes management drugs.
A new study published in the journal Science observed chin strap penguins in Antarctica and found that they take thousands of small naps a day each lasting only about four seconds.
